Donohoe Gary, Morris Derek W, De Sanctis Pierfilippo, Magno Elena, Montesi Jennifer L, Garavan Hugh P, Robertson Ian H, Javitt Daniel C, Gill Michael, Corvin Aiden P, Foxe John J
Neuropsychiatric Genetics Group, Institute of Molecular Medicine, Trinity College Dublin, St. James Hospital, Dublin, Ireland.
Biol Psychiatry. 2008 Mar 1;63(5):484-9. doi: 10.1016/j.biopsych.2007.07.022. Epub 2007 Oct 22.
Variation at the dysbindin gene (DTNBP1) has been associated with increased risk for schizophrenia in numerous independent samples and recently with deficits in general and domain-specific cognitive processing. The relationship between dysbindin risk variants and sensory-level deficits in schizophrenia remains to be explored. We investigated P1 performance, a component of early visual processing on which both patients and their relatives show deficits, in carriers and noncarriers of a known dysbindin risk haplotype.
Event-related potential responses to simple visual isolated-check stimuli were measured using high-density electrical scalp recordings in 26 individuals meeting DSM-IV criteria for schizophrenia, comprising 14 patients who were carriers of the dysbindin risk haplotype and 12 patients who were nonrisk haplotype carriers.
Carriers of the dysbindin risk haplotype demonstrated significantly reduced P1 amplitudes compared with noncarriers. A large effect size of d = .89 was calculated for the difference in P1 amplitude over scalp sites where the deficit was maximal.
The P1 deficits associated with a dysbindin risk haplotype previously identified in our sample presents functional confirmation of its deleterious effect on brain activity. Building on evidence of dysbindin's role in higher cognitive function, these early visual processing deficits suggest a generalized role for dysbindin in brain function and is likely to be part of the mechanism by which illness susceptibility is mediated.
在众多独立样本中,精神分裂症患者的失调结合蛋白基因(DTNBP1)变异与患病风险增加有关,最近还发现该基因与一般认知加工及特定领域认知加工缺陷有关。精神分裂症患者中失调结合蛋白风险变异与感觉水平缺陷之间的关系仍有待探索。我们调查了已知失调结合蛋白风险单倍型的携带者和非携带者的P1表现,P1是早期视觉加工的一个成分,患者及其亲属在该成分上均表现出缺陷。
使用高密度头皮电记录,测量了26名符合DSM-IV精神分裂症标准个体对简单视觉孤立方格刺激的事件相关电位反应,其中包括14名失调结合蛋白风险单倍型携带者和12名非风险单倍型携带者。
与非携带者相比,失调结合蛋白风险单倍型携带者的P1波幅显著降低。在头皮上P1波幅缺陷最大的部位,计算出d = 0.89的大效应量。
在我们的样本中,先前确定的与失调结合蛋白风险单倍型相关的P1缺陷,从功能上证实了其对大脑活动的有害影响。基于失调结合蛋白在高级认知功能中作用的证据,这些早期视觉加工缺陷表明失调结合蛋白在大脑功能中具有广泛作用,并且很可能是介导疾病易感性的机制的一部分。